Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)
Clinical trial NCT01439750 · UNKNOWN
Trial details
- NCT number
- NCT01439750
- Sponsor
- Milton S. Hershey Medical Center
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2018-08-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.